Regenxbio (RGNX) Net Cash Flow (QoQ) (2015 - 2025)
Regenxbio (RGNX) Net Cash Flow (QoQ) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Regenxbio |
315.11 Mn |
85.04 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-17.25% |
| Sep 30, 2025 |
58.94% |
| Jun 30, 2025 |
-169.64% |
| Mar 31, 2025 |
7,884.38% |
| Dec 31, 2024 |
179.18% |
| Sep 30, 2024 |
97.92% |
| Jun 30, 2024 |
-170.37% |
| Mar 31, 2024 |
518.46% |
| Dec 31, 2023 |
-20.53% |
| Sep 30, 2023 |
-1,128.67% |
| Jun 30, 2023 |
95.29% |
| Mar 31, 2023 |
-24.40% |
| Dec 31, 2022 |
-662.97% |
| Sep 30, 2022 |
95.99% |
| Jun 30, 2022 |
54.02% |
| Mar 31, 2022 |
-230.47% |
| Dec 31, 2021 |
509.70% |
| Sep 30, 2021 |
16.64% |
| Jun 30, 2021 |
26.70% |
| Mar 31, 2021 |
-119.14% |
